Literature DB >> 16706996

The impact of simvastatin on warfarin disposition and dose requirements.

E A Sconce, T I Khan, A K Daly, H A Wynne, F Kamali.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706996     DOI: 10.1111/j.1538-7836.2006.01974.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement.

Authors:  Shi-Long Zhong; Yuan Liu; Xi-Yong Yu; Dan Xu; Hong-Hong Tan; Qiu-Xiong Lin; Min Yang; Hai-Yan Lao; Shu-Guang Lin
Journal:  Eur J Clin Pharmacol       Date:  2011-02-12       Impact factor: 2.953

2.  Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.

Authors:  P A Lenzini; G R Grice; P E Milligan; M B Dowd; S Subherwal; E Deych; C S Eby; C R King; R M Porche-Sorbet; C V Murphy; R Marchand; E A Millican; R L Barrack; J C Clohisy; K Kronquist; S K Gatchel; B F Gage
Journal:  J Thromb Haemost       Date:  2008-07-24       Impact factor: 5.824

3.  Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.

Authors:  Babatunde O Sonuga; Derek A Hellenberg; Clint S Cupido; Cilia Jaeger
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-05-31

4.  VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.

Authors:  Silvia Misasi; Giuliana Martini; Oriana Paoletti; Stefano Calza; Giovanni Scovoli; Alessandra Marengoni; Sophie Testa; Luigi Caimi; Eleonora Marchina
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

5.  Synergistic effects of HMG-CoA reductase inhibitor and angiotensin II receptor blocker on load-induced heart failure.

Authors:  Yusuke Ito; Yasuhiro Maejima; Natsuko Tamura; Yuka Shiheido-Watanabe; Masanori Konishi; Takashi Ashikaga; Kenzo Hirao; Mitsuaki Isobe
Journal:  FEBS Open Bio       Date:  2018-04-10       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.